attachment
attachment
attachment
attachment

Solve this for me

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching Images

skeletal muscle structure diagram labeled

Anatomical diagram presenting an OpenSim musculoskeletal model from both anterior and posterior views for motion analysis. The skeletal structure is rendered in white, showcasing the skull, ribcage, vertebral column, pelvis, and limbs. Superimposed on the skeleton are muscle-tendon units depicted as red elongated structures, primarily concentrated in the lower body, including the gluteal, femoral, and crural regions. Numerous pink spheres are distributed across the model, representing motion capture markers positioned at strategic bony landmarks and joint centers such as the acromion, lateral epicondyles of the humerus, radial/ulnar styloids, greater trochanters, femoral condyles, and malleoli. This digital representation is used in biomechanical modeling to simulate human gait, joint kinematics, and muscle activation patterns, facilitating clinical research into movement disorders, surgical planning, or rehabilitation outcomes.

Anatomical diagram presenting an OpenSim musculoskeletal model from both anterior and posterior views for motion analysis. The skeletal structure is rendered in white, showcasing the skull, ribcage, vertebral column, pelvis, and limbs. Superimposed on the skeleton are muscle-tendon units depicted as red elongated structures, primarily concentrated in the lower body, including the gluteal, femoral, and crural regions. Numerous pink spheres are distributed across the model, representing motion capture markers positioned at strategic bony landmarks and joint centers such as the acromion, lateral epicondyles of the humerus, radial/ulnar styloids, greater trochanters, femoral condyles, and malleoli. This digital representation is used in biomechanical modeling to simulate human gait, joint kinematics, and muscle activation patterns, facilitating clinical research into movement disorders, surgical planning, or rehabilitation outcomes.

This composite educational illustration presents a comparison between biological skeletal muscle hierarchical structure and biomimetic electrospun polyurethane (PU) nanofibers. The central anatomical diagram (A) depicts a human arm transitioning into a detailed breakdown of muscle components, including the muscle belly, epimysium, fascicles, myofibers, and myofibrils. Integrated Scanning Electron Microscopy (SEM) images demonstrate how synthetic nanofibers can replicate these biological levels. Panel (B) shows a mat of aligned nanofibers mimicking the thin, parallel arrangement of myofibrils. Panel (C) illustrates a bundle of these nanofibers resembling a myofiber. Panel (D) provides a high-magnification cross-section of a synthetic aligned bundle, showing dense parallel internal packing. Panel (E) displays a cross-sectional view of a biological muscle belly for comparison, revealing rounded muscle fibers and surrounding membranes. Panel (F) shows an electrospun membrane with random nanofiber orientation, mimicking the structural properties and appearance of the epimysium that envelops biological muscle. This comparison highlights key concepts in bioengineering, tissue modeling, and the structural physiology of skeletal muscle.

This composite educational illustration presents a comparison between biological skeletal muscle hierarchical structure and biomimetic electrospun polyurethane (PU) nanofibers. The central anatomical diagram (A) depicts a human arm transitioning into a detailed breakdown of muscle components, including the muscle belly, epimysium, fascicles, myofibers, and myofibrils. Integrated Scanning Electron Microscopy (SEM) images demonstrate how synthetic nanofibers can replicate these biological levels. Panel (B) shows a mat of aligned nanofibers mimicking the thin, parallel arrangement of myofibrils. Panel (C) illustrates a bundle of these nanofibers resembling a myofiber. Panel (D) provides a high-magnification cross-section of a synthetic aligned bundle, showing dense parallel internal packing. Panel (E) displays a cross-sectional view of a biological muscle belly for comparison, revealing rounded muscle fibers and surrounding membranes. Panel (F) shows an electrospun membrane with random nanofiber orientation, mimicking the structural properties and appearance of the epimysium that envelops biological muscle. This comparison highlights key concepts in bioengineering, tissue modeling, and the structural physiology of skeletal muscle.

Searching Images

bacteria growth curve phases lag exponential stationary decline

This figure presents two comparison charts, (a) and (b), depicting the growth kinetics and metabolic activity of Lactococcus lactis over 360 minutes. The primary metrics are Optical Density (OD), indicating bacterial concentration, and Energy Rate measured via Acoustic Emission (AE) in attojoules per hit (aJ/Hit). Graph (a) shows normal bacterial growth: the OD curve follows a characteristic sigmoidal pattern with lag, log, and stationary phases, while the AE data exhibits significant fluctuations and distinct peaks (e.g., around 108 and 240 minutes) representing metabolic energy release. Graph (b) demonstrates the effect of the metabolic inhibitor Sodium Azide (NaN3). In this panel, the OD remains near-baseline (indicating total inhibition of growth), and the AE signal shows only low-level background fluctuations without significant metabolic peaks. Red bars indicate ±3σ deviation standards for noise assessment. These graphs are utilized in microbiology and biomedical engineering to evaluate non-invasive methods for monitoring microbial activity and metabolic inhibition.

This figure presents two comparison charts, (a) and (b), depicting the growth kinetics and metabolic activity of Lactococcus lactis over 360 minutes. The primary metrics are Optical Density (OD), indicating bacterial concentration, and Energy Rate measured via Acoustic Emission (AE) in attojoules per hit (aJ/Hit). Graph (a) shows normal bacterial growth: the OD curve follows a characteristic sigmoidal pattern with lag, log, and stationary phases, while the AE data exhibits significant fluctuations and distinct peaks (e.g., around 108 and 240 minutes) representing metabolic energy release. Graph (b) demonstrates the effect of the metabolic inhibitor Sodium Azide (NaN3). In this panel, the OD remains near-baseline (indicating total inhibition of growth), and the AE signal shows only low-level background fluctuations without significant metabolic peaks. Red bars indicate ±3σ deviation standards for noise assessment. These graphs are utilized in microbiology and biomedical engineering to evaluate non-invasive methods for monitoring microbial activity and metabolic inhibition.

This figure presents three line graphs (a, b, and c) detailing the biophysical monitoring of Lactococcus lactis growth and its response to c2 bacteriophage infection at 32°C. Each graph plots two distinct datasets against a horizontal axis of 'Minutes after inoculation.' The left vertical axis measures the Acoustic Emission (AE) Energy Rate in attojoules per hit (aJ/Hit), represented by a solid black line. The right vertical axis measures Optical Density (OD) at 600 nm, represented by a line with square markers. A dashed arrow at the 165-minute mark indicates the point of bacteriophage addition. The graphs show the progression of bacterial growth phases (lag, log, and stationary) via OD, followed by a decline in turbidity indicating cell lysis. The AE data displays transient energy peaks representing metabolic activity and phage-induced events, such as genome injection and lysis. Red error bars represent the ±3σ standard deviation threshold used to distinguish significant biological acoustic signals from background noise. These plots illustrate the application of acoustic emission as a real-time, non-invasive diagnostic tool for monitoring microbial dynamics and viral-host interactions.

This figure presents three line graphs (a, b, and c) detailing the biophysical monitoring of Lactococcus lactis growth and its response to c2 bacteriophage infection at 32°C. Each graph plots two distinct datasets against a horizontal axis of 'Minutes after inoculation.' The left vertical axis measures the Acoustic Emission (AE) Energy Rate in attojoules per hit (aJ/Hit), represented by a solid black line. The right vertical axis measures Optical Density (OD) at 600 nm, represented by a line with square markers. A dashed arrow at the 165-minute mark indicates the point of bacteriophage addition. The graphs show the progression of bacterial growth phases (lag, log, and stationary) via OD, followed by a decline in turbidity indicating cell lysis. The AE data displays transient energy peaks representing metabolic activity and phage-induced events, such as genome injection and lysis. Red error bars represent the ±3σ standard deviation threshold used to distinguish significant biological acoustic signals from background noise. These plots illustrate the application of acoustic emission as a real-time, non-invasive diagnostic tool for monitoring microbial dynamics and viral-host interactions.

Here are complete answers to all questions in your BPT Semester I exam paper:

SECTION B - Short Answer Questions


ANATOMY [2 marks]

Q1. Draw a well-labeled diagram of skeletal muscle

Skeletal Muscle - Structural Hierarchy:
MUSCLE (whole organ)
│
├── Epimysium - dense CT sheath surrounding entire muscle
│
├── Fascicle (bundle of fibers)
│   └── Perimysium - surrounds each fascicle
│
└── Muscle Fiber (single cell)
    └── Endomysium - surrounds each fiber
        │
        └── MYOFIBRIL
            │
            ├── I-band (light) - actin only
            ├── A-band (dark) - actin + myosin overlap
            ├── H-zone - myosin only
            ├── Z-line - anchors actin, defines sarcomere
            └── M-line - center of H-zone
Diagram:
Epimysium
 ┌──────────────────────────────┐
 │  Perimysium                  │
 │  ┌─────────────┐             │
 │  │ Fascicle    │  ← Fascicle │
 │  │ ┌──────┐   │             │
 │  │ │Fiber │   │  ← Muscle   │
 │  │ │  ↑   │   │    Fiber    │
 │  │ │ Endo │   │             │
 │  │ │ mysm │   │             │
 │  │ └──────┘   │             │
 │  └─────────────┘             │
 └──────────────────────────────┘

Sarcomere (one unit):
Z────I────A────H────A────I────Z
     actin  myosin  actin
The key proteins are actin (thin filaments, ~6 nm) and myosin (thick filaments, ~10 nm). Contraction occurs by the sliding filament mechanism - myosin heads pull actin toward the center, shortening the sarcomere.

BIOCHEMISTRY [6 marks]

Q2. Synthesis and Importance of Melanin

Melanin is the pigment responsible for skin, hair, and eye color. It is synthesized in melanocytes (derived from neural crest cells) within specialized organelles called melanosomes.
Synthesis Pathway:
Phenylalanine
     ↓ (Phenylalanine hydroxylase)
L-Tyrosine
     ↓ (Tyrosinase - rate-limiting, copper-dependent)
DOPA (3,4-dihydroxyphenylalanine)
     ↓ (Tyrosinase)
Dopaquinone
     ↓
     ├──→ Eumelanin (brown/black) - via cyclization & polymerization
     └──→ Pheomelanin (red/yellow) - via cysteine addition
Types:
  • Eumelanin - brown/black pigment; predominant in darker skin
  • Pheomelanin - red/yellow pigment; predominant in fair/red-haired individuals
Importance of Melanin:
  1. Photoprotection - absorbs and scatters UV radiation, protecting DNA from UV-induced mutations
  2. Skin color - determines racial/ethnic skin pigmentation
  3. Antioxidant - scavenges free radicals
  4. Eye protection - in choroid and retinal pigment epithelium, reduces light scatter
  5. Neurological role - neuromelanin in dopaminergic neurons of substantia nigra (its loss is seen in Parkinson's disease)
Clinical correlation: Albinism results from a deficiency/absence of functional tyrosinase, leading to absent melanin, hypopigmentation, photosensitivity, and increased risk of skin cancer.

Q3. Biochemical Basis of Organophosphate Poisoning

Organophosphates (e.g., malathion, parathion, nerve agents) inhibit the enzyme acetylcholinesterase (AChE).
Normal mechanism:
Acetylcholine (ACh) → AChE → Choline + Acetate (inactivation)
In organophosphate poisoning:
Organophosphate + AChE → Phosphorylated AChE (irreversible inhibition)
                            ↓
            ACh accumulates at synapses
Consequences of ACh accumulation:
Receptor TypeLocationEffect (SLUDGE)
Muscarinic (M)Glands, smooth muscle, heartSalivation, Lacrimation, Urination, Defecation, GI cramps, Emesis; bradycardia, miosis, bronchospasm
Nicotinic (N)NMJ, autonomic gangliaMuscle fasciculations, weakness, paralysis
CNSBrainSeizures, coma, respiratory depression
Key biochemical point: The phosphorylated AChE undergoes "aging" - the phosphate bond becomes even more irreversible over time. Oximes (e.g., pralidoxime/2-PAM) can regenerate AChE if given early, before aging occurs.

Q4. Define and Classify Carbohydrates with Examples

Definition: Carbohydrates are polyhydroxy aldehydes or ketones (or compounds that yield these on hydrolysis). General formula: (CH₂O)n.
Classification:
I. Monosaccharides (cannot be hydrolyzed further)
  • Based on carbon number: Trioses (C₃), Tetroses (C₄), Pentoses (C₅), Hexoses (C₆)
  • Based on carbonyl group: Aldoses (aldehyde - e.g., glucose) / Ketoses (ketone - e.g., fructose)
  • Examples: Glucose (C₆ aldose), Fructose (C₆ ketose), Galactose, Ribose (C₅)
II. Disaccharides (2 monosaccharides joined by glycosidic bond)
DisaccharideComponentsBond
Sucrose (table sugar)Glucose + Fructoseα1→β2
Lactose (milk sugar)Galactose + Glucoseβ1→4
Maltose (malt sugar)Glucose + Glucoseα1→4
III. Oligosaccharides (3-10 monosaccharide units)
  • Examples: Raffinose, Stachyose (in legumes)
IV. Polysaccharides (>10 units)
  • Homopolysaccharides (one type of sugar):
    • Starch (storage in plants) - amylose + amylopectin
    • Glycogen (storage in animals - liver, muscle)
    • Cellulose (structural in plants)
  • Heteropolysaccharides (different types of sugars):
    • Hyaluronic acid, Heparin (anticoagulant), Chondroitin sulfate (cartilage)

MICROBIOLOGY [6 marks]

Q5. Explain Bacteria Growth Curve

The bacterial growth curve represents the growth of a bacterial population in a closed (batch) culture system over time. It has 4 phases:
        Log of
        number
        of cells
           |                         ___
           |                       /    \
           |            _________/      \____
           |           /  Stationary
           |   _______/  Exponential
           |  / Lag
           |/_________________________
                        Time →
1. Lag Phase
  • No increase in cell number
  • Cells are metabolically active - synthesizing enzymes, RNA, adapting to new medium
  • Duration depends on medium composition and inoculum size
2. Log (Exponential) Phase
  • Cells divide at maximum rate by binary fission
  • Cell number doubles every generation time (doubling time)
  • Most metabolically active; most sensitive to antibiotics
  • Formula: N = N₀ × 2ⁿ (where n = number of generations)
3. Stationary Phase
  • Growth rate = Death rate (net zero growth)
  • Nutrients depleted, toxic metabolites accumulate
  • Spore formation occurs in this phase (e.g., Bacillus, Clostridium)
4. Decline (Death) Phase
  • Death rate > Growth rate
  • Bacteria die due to nutrient exhaustion and toxic waste
  • Some cells may persist (viable but non-culturable state)
Clinical relevance: Antibiotics that target cell wall synthesis (penicillin, cephalosporins) are most effective during the log phase when bacteria are actively dividing.

Q6. Classify Viruses with Examples

Classification of Viruses:
A. Based on Nucleic Acid:
TypeExamples
DNA virusesHerpes simplex (HSV), Hepatitis B, Adenovirus, Poxvirus, HPV
RNA virusesHIV, Influenza, Poliovirus, Rabies, SARS-CoV-2, Hepatitis C
B. Based on Symmetry of Capsid:
  • Icosahedral - Adenovirus, Poliovirus, Rhinovirus
  • Helical - Tobacco mosaic virus, Rabies
  • Complex - Poxvirus, Bacteriophages
C. Based on Envelope:
  • Enveloped (lipid bilayer): HIV, HSV, Influenza, Hepatitis C, Rabies
  • Non-enveloped (Naked): Poliovirus, Adenovirus, Rotavirus, HPV
D. Based on Host:
  • Animal viruses (pathogenic to humans)
  • Bacteriophages (infect bacteria)
  • Plant viruses
E. Baltimore Classification (replication strategy):
  • Class I: dsDNA (Herpesvirus, Adenovirus)
  • Class II: ssDNA (Parvovirus)
  • Class III: dsRNA (Reovirus)
  • Class IV: (+) ssRNA (Poliovirus, Hepatitis A)
  • Class V: (−) ssRNA (Influenza, Rabies)
  • Class VI: ssRNA-RT (HIV - Retroviruses)
  • Class VII: dsDNA-RT (Hepatitis B)

Q7. Different Modes of Transmission of Disease with Examples

ModeDescriptionExamples
Direct contactPhysical contact between source and hostSTIs (Gonorrhea, Syphilis), Scabies, Ringworm
DropletLarge droplets (>5 µm), travel <1 mInfluenza, Common cold, COVID-19, Mumps, Measles
AirborneDroplet nuclei (<5 µm), remain suspendedTB (M. tuberculosis), Measles, Chickenpox
Fecal-oralIngestion of contaminated food/waterCholera, Typhoid, Polio, Hepatitis A, Rotavirus
Vector-borne- Biological vector (pathogen multiplies): Malaria (Anopheles mosquito), Dengue (Aedes), Plague (fleas) - Mechanical vector (no multiplication): Housefly (typhoid)
Fomite (Indirect)Contaminated inanimate objectsConjunctivitis (towels), Hepatitis B (needles)
ZoonosisAnimal-to-human transmissionRabies (dog bite), Brucellosis (cattle), Anthrax
Vertical (Mother to child)Transplacental, during birth, breastfeedingHIV, Rubella, Toxoplasmosis, Hepatitis B
Parenteral/Blood-borneContact with infected blood/body fluidsHIV, Hepatitis B, Hepatitis C

PATHOLOGY [6 marks]

Q8 (circled 5). Cellular Adaptations with Examples

Cellular adaptations are reversible changes in cell size, number, phenotype, or function in response to stress.
AdaptationDefinitionExample
HypertrophyIncrease in cell size (not number); no cell divisionCardiac hypertrophy in hypertension; skeletal muscle in weight training
HyperplasiaIncrease in cell number by mitosisEndometrial hyperplasia (estrogen excess); compensatory liver hyperplasia
AtrophyDecrease in cell size (and sometimes number)Muscle wasting in disuse; brain atrophy in Alzheimer's
MetaplasiaReversible change of one differentiated cell type to anotherBarrett's esophagus (squamous → columnar); smoker's bronchi (columnar → squamous)
DysplasiaDisordered cell growth - abnormal size, shape, organizationCervical dysplasia (CIN) - precancerous
AplasiaFailure of an organ to developAplastic anemia (bone marrow fails to produce cells)

Q9 (circled 6). Pathophysiology of Edema

Edema = abnormal accumulation of fluid in the interstitial space.
Normal fluid balance (Starling forces):
Capillary filtration OUT = Capillary hydrostatic pressure (Pc) - Plasma oncotic pressure (πp)
Fluid return IN = Interstitial oncotic pressure (πi) - Interstitial hydrostatic pressure (Pi)
Mechanisms leading to edema:
1. Increased Capillary Hydrostatic Pressure
  • Venous obstruction, heart failure, portal hypertension
  • Fluid pushed out of capillaries into interstitium
  • Example: Ankle edema in right heart failure
2. Decreased Plasma Oncotic Pressure (↓ Albumin)
  • Nephrotic syndrome (protein loss in urine), liver cirrhosis (↓ albumin synthesis), malnutrition (kwashiorkor)
  • Less fluid drawn back into capillaries
3. Increased Vascular Permeability
  • Inflammation, allergy, histamine, bradykinin
  • Protein leaks out → raises interstitial oncotic pressure
  • Example: Angioedema, insect bites
4. Lymphatic Obstruction (Lymphedema)
  • Failure of lymphatics to drain interstitial fluid
  • Example: Filariasis (elephantiasis), post-mastectomy arm edema
5. Sodium and Water Retention
  • Renal failure, hyperaldosteronism
  • Increases intravascular volume → increases Pc

Q10 (circled 7). Tuberculoid vs. Lepromatous Leprosy

FeatureTuberculoid Leprosy (TT)Lepromatous Leprosy (LL)
Immune responseStrong CMI (cell-mediated)Weak CMI; strong humoral
Lepromin testPositiveNegative
Bacillary loadPaucibacillary (few bacilli)Multibacillary (many bacilli)
Skin lesionsFew (1-5), well-defined, hypopigmented, raised edges, dryNumerous, ill-defined, diffuse; leonine facies, madarosis (loss of eyebrows)
SensationMarkedly reduced/absent (anesthesia)Mildly reduced/preserved initially
NervesFew, enlarged, palpable, asymmetricMultiple, symmetrically involved, less enlarged
Nasal involvementAbsentSaddle nose deformity (nasal septum collapse)
Bacteriology (slit-skin smear)Negative (AFB absent)Positive (abundant AFB - globi)
HistologyEpithelioid granulomas with lymphocytes; no bacilliFoamy (Virchow) macrophages full of bacilli; no granulomas
PrognosisSelf-limiting; good prognosisProgressive; needs prolonged treatment
Treatment6-month MDT (Rifampicin + Dapsone)12-month MDT (Rifampicin + Dapsone + Clofazimine)

PHARMACOLOGY [8 marks]

Q11 (Q8 in paper). Management of Organophosphorus Poisoning

Emergency management - follow ABCs:
1. Stabilization
  • Secure airway (risk of bronchospasm + secretions)
  • Oxygen supplementation / mechanical ventilation if needed
  • Remove contaminated clothing; copious skin/eye washing (decontamination)
2. Specific Antidotes:
A. Atropine (Antimuscarinic)
  • Blocks muscarinic receptors - counteracts SLUDGE effects
  • Initial dose: 2-4 mg IV (adults); repeat every 5-10 minutes
  • Titration endpoint: drying of secretions (not heart rate)
  • May need very large doses (up to 100+ mg in severe cases)
B. Pralidoxime (2-PAM, Oxime)
  • Reactivates phosphorylated AChE before "aging"
  • Dose: 1-2 g IV over 15-30 minutes, then infusion
  • Must be given early (within 24-48 hours); ineffective after aging
  • Addresses nicotinic effects (muscle weakness, paralysis) that atropine cannot
C. Benzodiazepines
  • For seizure control (diazepam 5-10 mg IV)
3. Supportive care:
  • Treat bronchospasm with atropine (not beta-agonists)
  • Monitor cardiac rhythm (QTc prolongation risk)
  • Correct electrolyte imbalances
  • Gastric lavage if oral ingestion within 1 hour

Q12 (Q9 in paper). Beta-Blockers: Therapeutic Uses and Adverse Effects

Beta-blockers competitively block β-adrenergic receptors (β₁, β₂, β₃).
Types:
  • Non-selective: Propranolol, Carvedilol (also α-blocker), Labetalol
  • Cardioselective (β₁ selective): Metoprolol, Atenolol, Bisoprolol, Esmolol
  • With ISA (intrinsic sympathomimetic activity): Pindolol
Therapeutic Uses:
IndicationMechanism
Hypertension↓ Cardiac output, ↓ Renin release
Angina pectoris↓ Heart rate and contractility → ↓ O₂ demand
Post-MI (secondary prevention)Cardioprotection, antiarrhythmic
Heart failure (chronic stable)Metoprolol, bisoprolol, carvedilol - reduce mortality
Arrhythmias (SVT, AF rate control)↓ AV node conduction
GlaucomaTimolol eye drops - ↓ aqueous humor production
Hyperthyroidism (thyrotoxicosis)↓ Sympathetic symptoms (tremor, palpitation)
Migraine prophylaxisPropranolol
Anxiety/performance anxietyPropranolol (blocks peripheral tremor, palpitations)
PheochromocytomaUsed with alpha-blocker first
Esophageal varicesPropranolol - ↓ portal pressure
Adverse Effects:
SystemEffect
CardiovascularBradycardia, hypotension, heart block, worsening heart failure (acute)
RespiratoryBronchospasm (dangerous in asthma/COPD - avoid non-selective)
CNSFatigue, sleep disturbances, nightmares, depression
MetabolicHyperglycemia masking (blunts hypoglycemia warning signs in diabetics); dyslipidemia
SexualErectile dysfunction
ReboundRebound hypertension/angina if stopped abruptly
Contraindications: Asthma, COPD (non-selective), acute decompensated heart failure, 2nd/3rd degree heart block, bradycardia.

Q13 (Q10 in paper). Receptors: Definition and Types

Definition: Receptors are specific macromolecular structures (usually proteins) located on the cell surface or intracellularly that bind with a drug/ligand with high specificity and affinity to produce a biological response.
Types of Receptors:
1. Ligand-Gated Ion Channels (Ionotropic)
  • Binding opens/closes ion channels directly
  • Fast response (milliseconds)
  • Examples: Nicotinic ACh receptor (Na⁺/K⁺), GABA-A receptor (Cl⁻), Glutamate (NMDA) receptor
2. G-Protein Coupled Receptors (GPCRs) / Metabotropic
  • 7-transmembrane domain receptors
  • Linked to Gα, Gβγ subunits → activate second messengers
  • Moderate response (seconds-minutes)
  • Subtypes:
    • Gs → ↑ adenylyl cyclase → ↑ cAMP (β-adrenergic, D1)
    • Gi → ↓ cAMP (α₂-adrenergic, D2, M2)
    • Gq → ↑ phospholipase C → IP₃ + DAG (M1, M3, α₁, H1)
  • Examples: Adrenergic, Muscarinic, Dopamine, Histamine receptors
3. Enzyme-Linked Receptors (Kinase-Linked)
  • Single transmembrane; intracellular domain has enzymatic activity
  • Mostly tyrosine kinase activity
  • Slow response (hours-days)
  • Examples: Insulin receptor, Growth hormone receptor, EGF receptor, IGF receptor
4. Nuclear/Intracellular Receptors
  • Located in cytoplasm or nucleus
  • Bind lipid-soluble ligands that cross cell membrane
  • Regulate gene transcription
  • Slowest response (hours-days)
  • Examples: Steroid receptors (glucocorticoids, sex hormones), Thyroid hormone receptor, Vitamin D receptor

Q14 (Q11 in paper). Bioavailability: Definition and Factors Affecting It

Definition: Bioavailability (F) is the fraction (or percentage) of an administered drug dose that reaches the systemic circulation in unchanged (active) form and the rate at which it does so.
  • For IV drugs: Bioavailability = 100% (by definition)
  • For oral drugs: F = AUC_oral / AUC_IV × 100%
Factors Affecting Bioavailability:
1. Pharmaceutical factors (drug formulation):
  • Tablet disintegration and dissolution rate
  • Particle size (smaller = better absorption)
  • Polymorphic forms of drug
  • Excipients used in formulation
2. Drug-related factors:
  • Lipid solubility - lipophilic drugs cross membranes better
  • Molecular size - small molecules absorbed better
  • pKa and pH - affects ionization; unionized forms are absorbed
  • Chemical stability in GI tract (e.g., penicillin G destroyed by acid)
3. First-pass metabolism (hepatic/gut wall):
  • Most important factor reducing oral bioavailability
  • Drugs absorbed from gut → portal vein → liver → extensively metabolized before reaching systemic circulation
  • Examples of high first-pass drugs: Morphine, Propranolol, Lignocaine, GTN, Labetalol
4. Route of administration:
  • IV > IM > SC > Sublingual > Oral > Rectal > Topical (generally)
  • Sublingual/buccal bypass first-pass (e.g., GTN, buprenorphine)
5. GI factors:
  • Gastric emptying rate (faster = faster absorption)
  • GI motility, pH, surface area
  • Food-drug interactions (food may ↓ or ↑ bioavailability)
  • P-glycoprotein (efflux pump) - reduces absorption
6. Drug interactions:
  • Enzyme inducers (e.g., rifampicin) → ↓ F
  • Enzyme inhibitors (e.g., ketoconazole) → ↑ F
  • Chelation (tetracycline + calcium/antacids → ↓ F)

PHYSIOLOGY [2 marks]

Q15 (Q12 in paper). Saltatory Conduction for Transmission of Action Potential

Saltatory conduction (from Latin saltare = to jump) is the mechanism by which action potentials propagate along myelinated nerve fibers by "jumping" from one node of Ranvier to the next.
Structural basis:
  • Myelinated fibers are covered by Schwann cells (PNS) or oligodendrocytes (CNS) forming a myelin sheath
  • Myelin is electrically insulating - prevents ion flow through the membrane
  • Nodes of Ranvier are gaps (~1 µm) between adjacent myelin segments where voltage-gated Na⁺ channels are densely concentrated
  • The distance between nodes is approximately 1-2 mm (internodal segment)
Mechanism:
Action potential at Node 1
        ↓
Local current flows through axoplasm 
(ions cannot cross myelinated segment)
        ↓
Current reaches Node 2 (threshold reached)
        ↓
Na⁺ channels open → Action potential at Node 2
        ↓
Repeats → AP "jumps" to Node 3, 4, 5...
Advantages of saltatory conduction:
  1. Faster conduction velocity - up to 120 m/s in myelinated A-α fibers (vs. 0.5-2 m/s in unmyelinated C-fibers)
  2. Energy efficient - Na⁺/K⁺ ATPase only needs to restore ionic gradients at nodes, not along entire axon length
  3. Conserves axonal space - allows fast conduction in small diameter fibers
Clinical relevance: In multiple sclerosis (MS), demyelination destroys the myelin sheath, abolishing saltatory conduction and slowing/blocking nerve transmission, causing weakness, sensory loss, and visual disturbances.

SECTION B - Clinical Based Questions


ANATOMY [10 marks]

Q16. Clinical Scenario: 18-year-old girl, short stature, broad chest, webbed neck, underdeveloped genitalia, small uterus, fatty ovaries, primary amenorrhea

a. Probable Diagnosis [1 mark]
Turner Syndrome (45,XO / Gonadal Dysgenesis)
This is the classic presentation: short stature + webbed neck + broad chest + primary amenorrhea + sexual infantilism + streak gonads (fatty ovaries on CT). The karyotype is 45,X (monosomy X).
The handwritten annotations on the paper (Down's, Klinefelter's, Patau's, Edwards, Edward's syndrome) are other chromosomal disorders - but the clinical picture here is definitively Turner syndrome.

b. Other Numerical Chromosomal Disorders with Examples [4 marks]
Numerical chromosomal disorders = Aneuploidy - abnormal number of chromosomes due to non-disjunction during meiosis.
DisorderKaryotypeFeatures
Down Syndrome (Trisomy 21)47,XX or XY +21Intellectual disability, flat facies, upslanting palpebral fissures, simian crease, Brushfield spots, congenital heart defects (ASD, VSD), hypotonia, Alzheimer's risk in adulthood. Most common viable autosomal trisomy.
Edwards Syndrome (Trisomy 18)47,XX or XY +18IUGR, overlapping fingers (index over middle), rocker-bottom feet, micrognathia, congenital heart defects, kidney malformations. Usually fatal within first year.
Patau Syndrome (Trisomy 13)47,XX or XY +13Holoprosencephaly, cyclopia, cleft lip/palate, polydactyly, microphthalmia. Usually fatal within weeks.
Klinefelter Syndrome47,XXYMales only: small testes (hypogonadism), infertility, gynaecomastia, tall stature, learning difficulties. Most common sex chromosome disorder in males.
Turner Syndrome45,XO(As above - the case question)
Triple X Syndrome47,XXXFemales: usually tall, fertile, often asymptomatic or mild learning difficulties
XYY Syndrome47,XYYMales: tall stature, fertile, increased impulsivity; usually no major abnormalities
Mechanism of non-disjunction:
  • Non-disjunction in Meiosis I - both homologous chromosomes go to same cell
  • Non-disjunction in Meiosis II - sister chromatids fail to separate
  • Risk increases with advancing maternal age (especially for trisomy 21)

Q17. Clinical Scenario: 25-year-old man, swelling of upper limb, road accident 2 months ago, nonunion of fracture humerus, mobility at upper and lower ends of humerus

a. Cause of Pain of Bone [1 mark]
The pain in bone (especially in nonunion) is caused by:
  • Periosteum - the outer fibrous covering of bone is richly supplied by sensory nerve fibers (mainly from somatic nerves). It is the most pain-sensitive structure of bone.
  • In nonunion: abnormal mobility at the fracture site stimulates periosteal pain receptors
  • Additionally: endosteum (inner lining), medullary vessels also carry nociceptive fibers
  • Substance P and prostaglandins released at fracture site sensitize nociceptors
The periosteum is the primary source of bone pain.

b. Parts and Blood Supply of Humerus with Diagram [4 marks]
Parts of Humerus:
              HEAD (articulates with glenoid)
             /
    GREATER TUBERCLE (external rotation muscles: IST)
   /
  LESSER TUBERCLE (internal rotation: subscapularis)
  |
  BICIPITAL GROOVE (intertubercular sulcus - long head of biceps)
  |
  SURGICAL NECK ← common fracture site
  |
  SHAFT
  |      ← Radial groove (spiral groove) on posterior surface
  |         (contains radial nerve + profunda brachii artery)
  |
  LOWER END:
  ├── CAPITULUM (lateral) - articulates with radius
  ├── TROCHLEA (medial) - articulates with ulna
  ├── MEDIAL EPICONDYLE (ulnar nerve runs behind it)
  ├── LATERAL EPICONDYLE
  ├── CORONOID FOSSA (anterior, accommodates coronoid process)
  ├── OLECRANON FOSSA (posterior, accommodates olecranon)
  └── RADIAL FOSSA (above capitulum)
Blood Supply of Humerus:
ArteryRegion Supplied
Anterior circumflex humeral artery (branch of axillary)Head of humerus (main supply to humeral head)
Posterior circumflex humeral artery (branch of axillary)Head and surgical neck
Profunda brachii (deep brachial) artery (branch of brachial)Shaft - runs in the radial/spiral groove
Nutrient artery (branch of brachial or its branches)Medullary cavity of shaft
Anastomoses around elbow (radial recurrent, ulnar recurrent, interosseous recurrent)Lower end of humerus
Clinical relevance to the case:
  • Nonunion of fracture can result from disrupted blood supply, inadequate immobilization, infection, or bone loss
  • Fracture of surgical neck can damage axillary nerve and circumflex humeral vessels
  • Fracture of shaft (especially mid-shaft) can injure the radial nerve in the spiral groove → wrist drop
  • Supracondylar fracture (lower end) can injure the brachial artery → Volkmann's ischemic contracture

PHYSIOLOGY [10 marks]

Q18. Clinical Scenario: 25-year-old female, dizziness, profuse sweating, rapid pulse, fatigue after outdoor sports on hot day; decreased BP, dry mucous membranes, reduced skin turgor; hypovolemia (heat exhaustion)

a. Major Mechanisms for Dissipation of Heat from Body + Role of Anterior Hypothalamus in Thermoregulation [5 marks]
Mechanisms of Heat Dissipation:
1. Radiation (60% at rest)
  • Transfer of heat as infrared electromagnetic waves from body surface to environment
  • Does not require direct contact
  • Works when environmental temperature < body temperature
2. Evaporation (20-25% at rest; up to 80% during exercise)
  • Sweating: sweat evaporates from skin surface (1 g sweat evaporating removes ~0.58 kcal)
  • Insensible water loss from lungs and skin
  • The ONLY mechanism when environmental temp > body temp
  • Crucial in this patient's case (profuse sweating on hot day)
3. Convection
  • Transfer of heat to moving air or fluid molecules at skin surface
  • Enhanced by wind/fans
  • Hot, still day reduces convective cooling
4. Conduction
  • Direct transfer of heat to cooler objects in contact with the body
  • Least important in most situations
5. Thermogenesis reduction
  • Decreasing metabolic heat production (reduced muscle activity)
  • Vasodilation of cutaneous vessels to bring warm blood to surface

Role of Anterior Hypothalamus in Thermoregulation:
The hypothalamus is the thermostat of the body. The anterior hypothalamus-preoptic area (POAH) is the primary heat dissipation center.
                 ┌─────────────────────────────┐
THERMORECEPTORS  │   HYPOTHALAMUS              │
(skin + blood)   │                             │
     ↓           │  Anterior/Preoptic = COOLING │
Core temp > 37°C →→ CENTER                     │
                 │         ↓                   │
                 │  • Inhibits posterior        │
                 │    (heat conservation)       │
                 │         ↓                   │
                 └─────────────────────────────┘
                           ↓
              Heat Dissipation Responses:
              • ↑ Sweating (cholinergic innervation)
              • Cutaneous vasodilation (↑ blood flow to skin)
              • Behavioral responses (seek cool environment)
              • Inhibition of shivering
              • Tachycardia
              • Panting (in animals)
Fever mechanism: Pyrogens (IL-1, IL-6, TNF-α) → stimulate PGE₂ synthesis in POAH → raises the set-point of thermostat → body feels "cold" despite normal/elevated temperature → shivering, vasoconstriction until new set-point reached.
Posterior hypothalamus = heat conservation center (shivering, vasoconstriction).
In this patient: Heat exhaustion - the thermoregulatory mechanisms (sweating, vasodilation) failed to keep up with heat gain → hypovolemia from excessive sweating → ↓ BP, ↑ pulse.

Q19. Clinical Scenario: 50-year-old patient, MSA (multiple system atrophy), urinary incontinence, constipation, orthostatic hypotension; impaired bladder/bowel control

a. Fight or Flight Response in ANS [2 marks]
The Fight or Flight (Sympathoadrenal) response is a whole-body stress response mediated by the sympathetic nervous system and adrenal medulla, preparing the organism for immediate physical action.
Stimulus: Perceived threat/danger → processed by amygdala → activates hypothalamus
Mediators: Norepinephrine (sympathetic nerves) + Epinephrine/Adrenaline (adrenal medulla)
Physiological responses:
SystemFight/Flight Response
Heart↑ Heart rate (β₁), ↑ Force of contraction → ↑ Cardiac output
Blood vesselsVasoconstriction in skin/viscera (α₁); Vasodilation in skeletal muscle (β₂) → blood redirected to muscles
LungsBronchodilation (β₂) → ↑ O₂ intake
EyesPupil dilation (mydriasis) - α₁ → improved vision
LiverGlycogenolysis (β₂) → ↑ blood glucose
AdiposeLipolysis → ↑ free fatty acids (energy)
GI tract↓ Peristalsis, sphincter contraction (α₁) - digestion is non-essential
BladderRelaxation of detrusor (β₃); sphincter contraction (α₁) - urinary retention
Sweat glandsSweating (cholinergic sympathetic)
Adrenal medullaReleases epinephrine and norepinephrine (amplifies the response)
Neurotransmitter: Preganglionic = ACh; Postganglionic = Norepinephrine (except sweat glands = ACh)

b. Effects of Parasympathetic Stimulation on Heart, Eye, and Urinary Bladder [3 marks]
Parasympathetic = "Rest and Digest" - mediated by ACh acting on muscarinic receptors
1. Heart (M₂ receptors):
  • ↓ Heart rate (negative chronotropy) - via hyperpolarization of SA node (↑ K⁺ conductance)
  • ↓ AV node conduction velocity (negative dromotropy) - can cause AV block in excess
  • ↓ Atrial contractility (minor effect on ventricles)
  • Net effect: Bradycardia and ↓ Blood pressure
2. Eye:
  • Sphincter pupillae contraction → Miosis (pupil constriction) - mediated by M₃
  • Ciliary muscle contraction → lens becomes more convex → Accommodation for near vision (M₃)
  • ↑ Aqueous humor drainage (minor)
  • Note: Parasympathomimetics (pilocarpine) are used in glaucoma to reduce intraocular pressure
3. Urinary Bladder (M₂, M₃ receptors):
  • Detrusor muscle contraction (M₃) → contracts the bladder wall → promotes micturition
  • Internal urethral sphincter relaxation (M₃) → allows urine flow
  • Net effect: Promotes urination (micturition)
Relevance to the case: In MSA, degeneration of autonomic preganglionic neurons impairs both sympathetic and parasympathetic control → urinary incontinence (lost sphincter control), constipation (lost GI parasympathetic tone), and orthostatic hypotension (lost sympathetic vasomotor control).

Summary of all questions answered:
  • Q1-4: Anatomy & Biochemistry (skeletal muscle diagram, melanin, organophosphate biochemistry, carbohydrates)
  • Q5-7: Microbiology (bacterial growth curve, virus classification, disease transmission modes)
  • Q8-11: Pathology & Pharmacology (cellular adaptations, edema, TB vs. lepromatous leprosy, organophosphate management)
  • Q12-15: Pharmacology & Physiology (beta-blockers, receptors, bioavailability, saltatory conduction)
  • Q16-17: Clinical Anatomy (Turner syndrome, chromosomal disorders, humerus anatomy/blood supply)
  • Q18-19: Clinical Physiology (heat dissipation/thermoregulation, fight-or-flight, parasympathetic effects)
This is a shared conversation. Sign in to Orris to start your own chat.